CDKN2A and non-small cell lung carcinoma: A more focused analysis of BM specimens from 73 NSCLC patients6 revealed more frequent copy number alterations in CDKN2A/B, MYC, YAP1, and MMP13 in BM specimens, as compared to a matched TCGA cohort.